(As of 8/31/2026)

NBI Innovators Fund Investor Series

(Global Equity)
FundGrade A+® Rating recipient
For more information about FundGrade click here
2024
2023




Inception Return
(8/31/1995) 		10.42 %
YTD Return 10.60 %
NAVPS
(9/18/2026) 		$95.94
Change $0.49 / 0.51 %
Growth of $10,000 (As of August 31, 2026)
MER 2.23 %
Assets ($mil) $294.00
Rank (1Yr) 1493/2074
Std Dev (3Yr) 15.56 %
Volatility Ranking (3Yr) 9/10
RRSP Eligibility Yes
Load No Load
Max Front End -
Max Back End -
Sales Status Open
 
Objective
The NBI Innovators Fund (formerly NBI Science and Technology Fund) aims to aggressively seek capital appreciation for investors over the long term (greater than five years) primarily by investing in global companies whose activities are partially focused on scientific and technological research.
Fund Manager

National Bank Investments Inc.

Portfolio Manager

National Bank Trust Inc.

Sub-Advisor

Iain Stealey, J.P. Morgan Investment Management Inc.

Robert C. Michele, J.P. Morgan Investment Management Inc.

Lisa Coleman, J.P. Morgan Investment Management Inc.

Andrew Headley, J.P. Morgan Investment Management Inc.

Jeffrey Hutz, J.P. Morgan Investment Management Inc.

Robert Cook , J.P. Morgan Investment Management Inc.

Thomas Hauser, J.P. Morgan Investment Management Inc.

Jeffrey Lovell, J.P. Morgan Investment Management Inc.

Manish Goyal, J.P. Morgan Investment Management Inc.

 
Asset Allocation
(As of August 31, 2026)
Sector Allocation
(As of August 31, 2026)
Geographic Allocation
(As of August 31, 2026)
Top 10 Holdings
NameAssetSectorGeographicPercent
Alphabet Inc Cl AUS EquityTechnologyUnited States6.62%
Microsoft CorpUS EquityTechnologyUnited States6.51%
Amazon.com IncUS EquityConsumer ServicesUnited States6.15%
NVIDIA CorpUS EquityTechnologyUnited States5.18%
Broadcom IncUS EquityTechnologyUnited States4.03%
Apple IncUS EquityTechnologyUnited States3.73%
Micron Technology IncUS EquityTechnologyUnited States3.09%
Cash and Cash EquivalentsCash and EquivalentsCash and Cash EquivalentCanada3.04%
Eli Lilly and CoUS EquityHealthcareUnited States2.46%
Mastercard Inc Cl AUS EquityFinancial ServicesUnited States2.31%

Performance Data (As of August 31, 2026)
  Return (%) Annualized Return (%)
Return 1 Mth 3 Mth 6 Mth YTD 1 Yr 3 Yr 5 Yr 10 Yr
Fund 2.23 1.23 12.35 10.60 13.09 19.16 13.05 17.81
Benchmark 1.68 2.49 11.04 15.91 23.39 21.39 12.84 13.17
Quartile Ranking 1 3 1 3 3 2 1 1

Calendar Return (%) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Fund 8.29 30.59 29.26 -12.89 14.22 37.42 35.74 4.61 26.55 7.74
Benchmark 16.60 26.84 19.37 -12.64 17.62 13.15 21.41 -1.79 16.29 5.18
Quartile Ranking 4 1 1 2 3 1 1 1 1 1

Website powered by © Fundata Canada Inc.
Mutual Fund Data provided by Fundata. | View Terms and Conditions of Use.
BofA Merill Lynch Indices used with permission.
© 2026 Fundata Canada Inc. All rights reserved. | View Privacy Policy | Contact Us.